Clinical Trial Update: Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring low level laser therapy combined with topical clonazepam for Burning Mouth Syndrome; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burning Mouth Syndrome

Drugs mentioned

• Low Level Laser Therapy
• topical clonazepam (clonazepam)

Snippet

Sponsor: Universidad Nacional Autonoma de Mexico | Conditions: Burning Mouth Syndrome | Phase 4 | Status: UNKNOWN